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Plant food supplements (PFS) receive great acceptance by European consumers. However, quality and efficacy of these
products remain a question of concern. The aim of this systematic review is to summarize and critically evaluate the
evidence for or against the efficacy of PFS for coping inflammatory conditions by considering epidemiological and human
intervention studies. The review, which consists of two parts, considers Olea europea L., Camellia sinensis L., Vitis vinifera
L., and Matricaria recutita L., which are herbal material frequently used also as food. The search retrieved 1251 publications.
By applying the inclusion/exclusion criteria, the final number of papers was 91. Vitis vinifera L. showed promising results,
but other trials should be performed in order to assessing the efficacy. Surprisingly, it was impossible to draw conclusions
for the anti-inflammatory effect of Camellia sinensis L. as green tea. No studies were found on the leaves of Olea europea
L. whereas more human trials are needed to assess the anti-inflammatory effect of olive oil. Only one study for Matricaria
recutita L. was selected. In conclusion, it is advisable to conduct further studies with more homogeneous population and
larger number of subjects by avoiding the heterogeneity of the herbal preparations considered.
Keywords Olea europea L., Matricaria recutita L., Vitis vinifera L., Camellia sinensis L., green tea, olive oil
INTRODUCTION
Inflammation is the first body’s response to infection or in-
jury, and is critical for both innate and adaptive immunity. It
can be considered as part of the complex biological response of
vascular tissues to harmful stimuli, such as pathogens, damaged
cells, or irritants. Uncontrolled inflammation often results in
chronic diseases such as arthritis, autoimmune disorders, degen-
erative joint diseases, rheumatisms, atherosclerosis, diabetes,
and even cancer.
Inflammation can be classified as either acute or chronic.
Acute inflammation is the initial response of the body to harmful
stimuli and is achieved by the increased movement of plasma
and leukocytes (especially granulocytes) from the blood into
the injured tissues. A cascade of biochemical events propa-
gates and matures the inflammatory response, involving the local
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vascular system and the immune system, and various cells within
the injured tissue. Prolonged inflammation, known as chronic
inflammation and characterized by the development of specific
humoral and cellular immune responses to the pathogens, leads
to a progressive degeneration of tissue and fibrosis (Feghali and
Wright, 1997).
Several mediators participate to the inflammatory pro-
cess; some are released immediately (i.e., histamine, sero-
tonin, etc.), some are synthesized and released within a short
time (prostaglandins, leukotrienes, platelet-activating factor,
etc.), some require the de novo synthesis (cytokines, adhesion
molecules, etc.). Several cytokines such as tumor necrosis fac-
tor (TNF), interferon (IFN), interleukin 1β (IL-1β) or toll like
receptor (TLR) ligands cooperate to induce the gene expression
of specific promoters. The induction of most among these genes
is dependent on the presence of binding sites for the nuclear
factor kB (NF-kB).
NF-kB transcription factors regulate genes involved in many
aspects of the inflammatory response (Bonizzi and Karin, 2004).
In response to a variety of pro-inflammatory stimuli such as
cytokines (i.e., TNF, IL-1β), or oxidative stress, NF-kB
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404 M. DELL’AGLI ET AL.
transcription factor induces pro-inflammatory genes encod-
ing for the synthesis of cytokines, chemokines, adhesion
molecules such as vascular cell adhesion molecules-1 (VCAM-
1), intercellular adhesion molecules-1 (ICAM-1), and E se-
lectin, cyclooxygenase-1 (COX-1) and 2, inducible nitric ox-
ide synthase (iNOS) and metalloproteases (MMP), including
MMP-9. However, excessive and prolonged expression of pro-
inflammatory mediators could be harmful to the host; therefore,
the search for compounds that are able to interfere with these
mechanisms by preventing a prolonged inflammation could be
useful for human health.
The plant kingdom has developed a multitude of secondary
metabolites, many of which are recognized as useful tools for the
maintenance of human health. Secondary metabolites, for which
some anti-inflammatory properties are reported, belong to the
chemical class of alkaloids (Souto et al., 2011), coumarins (Wu
et al., 2009), flavonoids (Serafini et al., 2010), chalcones (Yadav
et al., 2011), polyphenols (Gonzalez-Gallego et al., 2010), and
triterpene derivatives (Braca et al., 2011).
Botanicals and in particular plant food supplements (PFS)
receive great acceptance by European consumers. Potentially,
they can deliver significant health benefits at relatively low costs.
However, quality and efficacy of these products remain a ques-
tion of concern, and bottlenecks in risk and benefit assessments
need to be solved.
PlantLIBRA (PLANT food supplements: Levels of Intake,
Benefit and Risk Assessment) is an European Community
funded project aiming to foster the safe use of food supple-
ments containing botanicals or their preparations, by evaluating
the quality and health benefits of PFS, and by increasing science-
based decision-making by regulators and food chain operators.
PlantLIBRA is structured to develop, validate, and dissem-
inate data and methodologies for risk, and benefit assessment
and implement sustainable international cooperation. Part of the
project is dedicated to the methodology of benefit assessment for
PFS, application and validation. The first step was to review the
evidence for PFS benefit from epidemiological, clinical, and in-
tervention studies. A number of pathological conditions, where
PFS are commonly used, were identified and inflammation was
one of those.
The aim of this systematic review is to summarize and
critically evaluate the evidence for or against the efficacy of PFS
or substances (compounds or foods) relevant to PFS for coping
inflammatory conditions. Ten plants considered are: Olea
europea L., Camellia sinensis L., Vitis vinifera L., Boswellia
serrata Roxb., Matricaria recutita L., Symphytum officinalis
L., Calendula officinalis L., Curcuma longa L., Urtica dioica
L., and Harpagophytum procumbens L. The choice of these
botanicals in the reviewing process is based on PlantLIBRA
partners’ suggestions and on the list of plants present in Annex
1 of the project.
Epidemiological, clinical/human intervention studies using
PFS were then systematically examined and reviewed. The re-
view will be divided in two parts: (1) a first one considering the
literature regarding Olea europea L., Camellia sinensis L., Vitis
vinifera L., and Matricaria recutita L., which are herbal material
frequently used also as food; (2) a second part considering the
literature of the other botanical species more commonly used
as food supplements/medicinals. This publication relates to the
first part.
METHODS
Source and Search Strategy
Electronic literature searches were conducted using the fol-
lowing databases: Cochrane library, Scifinder Scholar, Embase,
and Pubmed from 1970 to 2010. They were searched for title
and abstract using the following search terms: Latin name of
the plant or common name matched with inflamm or phlogo-
sis or anti-inflammatory. Search limits were human trial, and
the English language. Keywords relevant to inflammation (i.e.,
cyclooxigenase, cytokines, adhesion molecules, etc.) were also
used as search terms. Bibliographies of the articles thus located
were scanned for further relevant publications.
For collecting epidemiological studies, the same terms were
used for searching title, abstract, and index terms for the 10
plant food supplements (PFS) (1) and for health area inflamma-
tion (2). Terms used for searching epidemiological studies (3)
were: “epidemiology”/exp or epidemiolog or “case control” or
cohort. We selected epidemiological studies for applicable PFS
and inflammation in two different ways and then merged the
results: (1) and (2) filtered by study type or (1) and (2) and (3).
Inclusion and Exclusion Criteria
Controlled human studies performed on healthy/unhealthy
populations were included. Randomization, even if preferable,
was not considered essential. Inclusion criteria were the use of
PFS as food, or pill/powder/extract, etc. Publications reporting
incomplete qualitative and quantitative analysis of PFS were
flagged but not excluded. Studies reporting co-treatments with
other PFS or other bioactive compounds were included. Studies
where general foodstuffs were fortified with PFS or studies
reporting on single compounds were not considered.
Other criteria of exclusion were: the use of botani-
cals for cosmetic, homeopathy, aromatherapy, topical use,
aerosol/inhalation, hygiene products (toothpaste, mouth rinse,
etc.). Publications regarding reviews, commentary, and patents
were not considered. Letters to the editor were considered only
if they reported new data not previously published. The sci-
entific quality of the publications was one of the criteria for
inclusion/exclusion. The methodological quality of the studies
was assessed by two authors (MDA and CDL) based on quality
of results presentation, presence or not of adequate statistical
analysis, well-characterized experimental design.
Two independent reviewers evaluated the papers; disagree-
ment was resolved by discussion between reviewers. A study
was included if both reviewers agreed that it met all the inclu-
sion criteria.
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PLANT FOOD SUPPLEMENTS HAVING ANTI-INFLAMMATORY PROPERTIES 405
Similar inclusion/exclusion criteria were used for epidemio-
logical studies. From the bulk of papers selected by the search
strategy described above, those not fulfilling the inclusion crite-
ria were excluded by reading the abstract. For remaining studies,
a customized version of the extraction database was used.
Data Extraction
A database (written in MS Access) was designed and im-
plemented to aid the data extraction process. Publications were
checked for duplicates, read in full by two authors, and subjected
to the in/out process following the inclusion/exclusion criteria
described above. 10% of the publications found were checked
by a second reviewer and compared, whereas 5% of the publi-
cations not excluded by the in/out procedure were checked by
a second reviewer and compared. Papers were stored in a refer-
ence manager (Endnote X1.0.3). A pdf file of each publication
was retrieved.
RESULTS AND DISCUSSION
Human/Intervention Studies
The search by title and abstract retrieved 1251 publications.
By removing the duplicates and applying the inclusion/ exclu-
sion criteria above described, the final number of papers was
91. These publications were uploaded in the database and the
in/out process led to 42 publications accepted and used for this
systematic review.
Among the papers rejected in the in/out sheet process, 35%
were excluded because the clinical trial was not controlled, 31%
because the health area was not related to inflammation, 10%
because the study was not dealing with the 4 plants chosen for
the systematic review, 5% because the study was performed in
vitro or ex vivo, 7% because the plant material was not used
as supplement or food; 12% because the scientific quality was
insufficient.
Tables 1–4 report the human trials related to Vitis vinifera
L., Camellia sinensis L., and Olea europea L. For each PFS,
the publications are listed in two columns: benefit/no benefit,
depending whether the study reported beneficial/non-beneficial
results. The change of biomarkers or hard end-points, that in this
review is defined as “symptom or the change of a physiological
state” (i.e., reduction of ulcer index in gastritis), was used as a
criterion by which a publication is listed under the “benefit” or
“no benefit” column.
Vitis vinifera L.
Thirteen publications were found: four studies described the
effect obtained with the use of grapes (Zern et al., 2005; Gupta
et al., 2008; Puglisi et al., 2008; Rankin et al., 2008), three the
effect with grape juice (Albers et al., 2004; Castilla et al., 2006),
three with seeds (Kalfin et al., 2002; Kar et al., 2006; Sano et al.,
2007), two with grape skin (Young et al., 2000; Myers et al.,
2010), and one with grape leaves (Abidov et al., 2006). The
results are reported in Table 1. Studies reporting the biological
activity of red wine were voluntarily excluded since it is not used
as food supplement and the presence of alcohol was considered
confounding.
Almost 20 inflammatory biomarkers including adhesion
molecules, cytokines, C reactive protein (CRP), prostaglandins,
nitric oxide (NO), tromboxane derivatives, and markers of ox-
idative stress such as malonyl dialdehyde (MDA) have been
investigated. The subjects recruited in studies reporting benefits
were 608 versus 84 with no benefits. In studies reporting hard
end-points the number of subjects recruited in studies reporting
benefits was 492 versus 0 subjects with no benefits.
The search has evidenced that in most studies the number of
subjects is limited, and the type of treatment is heterogeneous,
since they were performed with PFS of different composition,
i.e.: entire fruit, fruit juice, seeds or fruit skin. In addition, epi-
demiological studies are not available (see below). Therefore,
even if the available data are promising, it will be desirable to
perform other trials in order to assessing the efficacy.
Camellia sinensis L.
The leaves of Camellia sinensis L. can be used to pre-
pare green or black tea. The effect of Camellia sinensis L. on
biomarkers of inflammation has been extensively investigated:
19 studies reported the effect of green tea (Freese et al., 1999;
Klaunig et al., 1999; Goudev et al., 2000; Nagaya et al., 2004;
Chiu et al., 2005; Erba et al., 2005; Fukino et al., 2005; Hirano-
Ohmori et al., 2005; Nagao et al., 2005; Ryu et al., 2006; Rowe
et al., 2007; Panza et al., 2008; Janjua et al., 2009; Nantz et al.,
2009; Bakker et al., 2010; Eichenberger et al., 2010; Fenercioglu
et al., 2010; Oyama et al., 2010; Basu et al., 2011) (Table 2),
6 studies for black tea (Hodgson et al., 2000; Hodgson et al.,
2001; O’Really et al., 2001; Widlansky et al., 2005; Mukamal
et al., 2007; Steptoe et al., 2007) (Table 3), and 4 studies consid-
ered both preparations (van het Hof et al., 1997; Hodgson et al.,
2000; de Maat et al., 2000; Hodgson et al., 2002). As regards
green tea and biomarkers, studies reporting benefit recruited 552
subjects versus 389 where no effect was observed. Similarly the
studies reporting the positive effect of green tea on hard end-
points recruited 539 subjects versus 419 with no benefits. The
studies dealing with black tea, the number of subjects recruited
in trials that do not reporting benefits was higher either in those
investigating the change of biomarkers (334 vs. 129) and hard
end-points (268 vs. 0).
In spite of 29 studies found, the available data are still much
contradictory. As green tea is concerned, only MDA levels
and oxidative stress was positively affected. Other biomark-
ers of inflammation remained unaffected or diminished in a
limited number of subjects. It is also to be noted the hetero-
geneity of inflammatory conditions where green tea was tested.
The consequence is the impossibility to draw conclusions as
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406 M. DELL’AGLI ET AL.
Table 1 Clinical studies considering the effect of Vitis vinifera L. on biomarkers and/or hard endpoints
No benefit Benefit
N◦ studies
N◦
participants N◦ studies
N◦
participants
Comments
Efficacy
Biomarkers
CRP 3 (Albers et al., 2004; Castilla et al.,
2008; Rankin et al., 2008)
69 3 (Zern et al., 2005; Castilla et al.,
2006; Kar et al., 2006)
117 OSN∗
Complement C3 protein 1 (Castilla et al., 2008) 32 OSN
MDA 1 (Young et al., 2000) 15 2 (Kalfin et al., 2002; Sano et al.,
2007)
263 YES
IL-6 1 (Rankin et al., 2008) 17 1 (Zern et al., 2005) 44 OSN
IL-8 1 (Albers et al., 2004) 20 OSN
CD-40 L 1 (Albers et al., 2004) 20 OSN
Monocyte chemotactic protein-1
(MCP-1)
2 (Castilla et al., 2006; Castilla et al.,
2008)
73 OSN
TNF-α 2 (Zern et al., 2005; Puglisi et al.,
2008)
78 OSN
E-selectin 1 (Kalfin et al., 2002) 202 YES
P-selectin 1 (Albers et al., 2004) 20 OSN
Phagocytosis of granulocytes 1 (Myers et al., 2010) 21 OSN
COX2 expression 1 (Myers et al., 2010) 21 OSN
8-epi-prostaglandin-F2-alfa 2 (Abidov et al., 2006; Rankin et al.,
2008)
61 OSN
PG-F2 (Prostaglandin F2) 1 (Gupta et al., 2008) 60 OSN
VCAM-1 2 (Castilla et al., 2008; Rankin et al.,
2008)
49 2 (Kalfin et al., 2002; Castilla et al.,
2006)
243 YES
ICAM-1 4 (Kalfin et al., 2002; Castilla et al.,
2006; Castilla et al., 2008; Puglisi
et al., 2008)
309 YES
Tromboxane (B2) TXB2 1 (Albers et al., 2004) 20 OSN
11-deydro-TXB2 1 (Abidov et al., 2006) 44 OSN
Nitric oxide (NO) 1 (Albers et al., 2004) 20 OSN
TOTAL 4a 84b 12c 608d
Hard end-points
Reduction of platelet-dependent
inflammatory indices
1 (Albers et al., 2004) 20 OSN
Reduction of oxidative stress in
healthy subjects
5 (Young et al., 2000; Abidov et al.,
2006; Castilla et al., 2006; Sano
et al., 2007; Rankin et al., 2008)
178 YES
Reduction of oxidative stress in
systemic sclerosis
1 (Kalfin et al., 2002) 202 YES
Reduction of inflammation in
systemic sclerosis
1 (Kalfin et al., 2002) 202 YES
Reduction of oxidative stress in
hemodialysis patients
1 (Castilla et al., 2006) 41 OSN
Reduction of inflammation in
hemodialysis patients
2 (Castilla et al., 2006; Castilla et al.,
2008)
73 OSN
Antipiretic effect 1 (Gupta et al., 2008) 60 OSN
TOTAL 0a 0b 9c 492d
∗OSN: other studies needed; a) number of studies where the effect was not observed; b) the total number of subjects recruited in the studies which reported no
benefit; c) number of studies where the effect was observed; d) the total number of subjects recruited in the studies which reported benefit.
for the anti-inflammatory effect of green tea. As black tea is
concerned, all data are against a possible anti-inflammatory
activity.
Matricaria recutita L.
In the retrieved papers, chamomile was mainly used in for-
mulations for aerosol/inhalation, toothpaste, and mouth rinse,
then according to the in/out process only one paper could be
selected (Becker et al., 2006). This study recruited 255 children
with acute diarrhoea. A reduction of the duration of diarrhea and
stool frequency, considered as hard end-points, was recorded.
No human studies reported the effect of chamomile on inflam-
matory biomarkers. In spite of the long-term traditional use of
chamomile for gastrointestinal inflammatory disorders, studies
with chamomile as PFS addressing this state are inexistent, with
the exception of the one selected for this review. Considering the
absence of epidemiological studies (see below), then this topic
urges further well-designed studies focusing on gastrointestinal
inflammation.
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Table 2 Clinical studies considering the effect of Camellia sinensis L. (green tea) on biomarkers and/or hard endpoints
No benefit Benefit
N◦ studies
N◦
participants N◦ studies
N◦
participants
Comments
Efficacy?
Biomarkers
CRP 5 (de Maat et al., 2000; Fukino et al.,
2005; Ryu et al., 2006; Bakker
et al., 2010; Basu et al., 2011)
256 2 (Oyama et al. 2010; Eichenberger
et al., 2010)
39 NO
Alpha-amiloid 1 (Nantz et al., 2009) 111 OSN∗
MDA 2 (van het Hof et al., 1997; Erba,
2005)
49 5 (Freese et al., 1999; Klaunig et al.,
1999; Nagao et al., 2005; Nantz
et al., 2009; Fenercioglu et al.,
2010)
307 YES
Adiponectin 2 (Bakker et al., 2010; Basu et al.,
2011)
71 OSN
IL-6 4 (de Maat et al., 2000; Ryu et al.,
2006; Eichenberger et al., 2010;
Basu et al., 2011)
163 OSN
IL-1β 2 (de Maat et al., 2000; Basu et al.,
2011)
99 OSN
CD-40 L 1 (Oyama et al. 2010) 30 OSN
MCP-1 1 (Oyama et al. 2010) 30 OSN
MIF (macrophage migration
inhibitory factor
1 (Oyama 2010) 30 OSN
TNF-α 1 (de Maat et al., 2000) 64 OSN
IFN-γ 1 (Rowe et al., 2007) 124 OSN
Leptin 1 (Basu et al., 2011) 35 OSN
Fibrinogen 1 (de Maat et al., 2000) 64 OSN
F-2 isoprostanes 1 (Hodgson et al. 2002) 13 OSN
8-isoprostaglandin-F2-α 1 (Nagaya et al., 2004) 20 1 (Freese et al., 1999) 20 OSN
8-epi-prostaglandin-F2-α 1 (Hirano-Ohmori et al., 2005) 22 OSN
6-keto-PGF2α 1 (Hirano-Ohmori et al., 2005) 22 OSN
VCAM-1 1 (Basu et al., 2011) 35 1 (Goudev et al., 2000) 60 OSN
ICAM-1 1 (Basu et al., 2011) 35 1 (Goudev et al., 2000) 60 OSN
Metalloproteinases (MMPs) 1 (Hirano-Ohmori et al., 2005) 22 OSN
Tromboxane (B2) TXB2 1 (Hirano-Ohmori et al., 2005) 22 OSN
F2a, 2,3-dinor thromboxane B2 1 (Freese et al., 1999) 20 OSN
Nitric oxide (NO) 1 (Freese et al., 1999) 20 OSN
TOTAL 12a 389b 10c 552d
Hard end-points
Inflammation changes in diabetes
or borderline diabetes
2 (Fukino et al., 2005; Ryu et al.,
2006)
121 1 (Fenercioglu et al., 2010) 114 OSN
Reduction of oxidative stress in
healthy subjects
3 (van het Hof et al., 1997;
Hirano-Ohmori et al., 2005;
Bakker et al., 2010)
83 9 (Freese et al., 1999; Klaunig et al.,
1999; Hodgson et al., 2000);
Nagaya et al., 2004; Erba, 2005;
Nagao et al., 2005; Panza et al.,
2008; Nantz et al., 2009; Oyama
et al. 2010)
301 YES
Inflammatory status in metabolic
syndrome
1 (Basu et al., 2011) 35 OSN
Reduction of flu symptoms 1 (Rowe et al., 2007) 124 OSN
Irritation in photoaging 2 (Chiu et al., 2005; Janjua et al.,
2009)
96 OSN
TOTAL 8a 419b 11c 539d
∗OSN: other studies needed; a) number of studies where the effect was not observed; b) the total number of subjects recruited in the studies which reported no
benefit; c) number of studies where the effect was observed; d) the total number of subjects recruited in the studies which reported benefit.
Olea europea L.
No studies were found concerning the use of the leaves of
Olea europea. All the studies (n = 6) performed with Olea euro-
pea and selected by the in/out process were directed to evaluate
the effect of olive oil consumption on human health. Five studies
for a total of 985 subjects investigated a variety of inflammation
biomarkers (Pacheco et al., 2008; Konstantinidou et al., 2010).
The results showed that the levels of VCAM-1, ICAM-1, IL-6,
and E-selectin, isoprostane and IFN-γ , were modified by the
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Table 3 Clinical studies considering the effect of Camellia sinensis L. (black tea) on biomarkers and/or hard endpoints
No benefit Benefit
N◦ studies N◦ participants N◦ studies
N◦
participants
Comments
Efficacy
Biomarkers
CRP 3 (de Maat et al., 2000; Widlansky et al.,
2005; Mukamal et al., 2007)
158 1 (Steptoe et al., 2007) 75 NO/OSN∗
MDA 2 (van het Hof et al., 1997; O’Reilly et al.,
2001)
57 YES
IL-6 2 (de Maat et al., 2000; Mukamal et al.,
2007)
92 OSN
IL-1β 1 (de Maat et al., 2000) 64 OSN
TNF-α 2 (de Maat et al., 2000; Mukamal et al.,
2007)
92 OSN
E-selectin 1 (Hodgson et al., 2001) 22 OSN
P-selectin 1 (Steptoe et al., 2007) 75 1 (Hodgson et al., 2001) 22 OSN
Fibrinogen 3 (de Maat et al., 2000; Hodgson et al.,
2001; Mukamal et al., 2007)
114 OSN
8-isoprostane 1 (Widlansky et al., 2005) 66 OSN
F-2 isoprostanes 1 (Hodgson et al., 2002) 22 OSN
8-epi-prostaglandin-F2-α 1 (O’Reilly et al., 2001) 32 OSN
VCAM-1 2 (Hodgson et al., 2001; Mukamal et al.,
2007)
50 OSN
ICAM-1 2 (Hodgson et al., 2001; Mukamal et al.,
2007)
50 OSN
t-PA 2 (Hodgson et al., 2001; Mukamal et al.,
2007)
50 OSN
PAI-1 1 (Hodgson et al., 2001) 22 OSN
vWF 1 (Mukamal et al., 2007) 28 OSN
Leukocyte-platelet aggregates 1 (Steptoe et al., 2007) 75 OSN
TOTAL 8a 334b 3c 129d
Hard end-points
Inflammation changes in diabetes or
borderline diabetes
1 (Mukamal et al., 2007) 28 OSN
Reduction of oxidative stress in
healthy subjects
5 (van het Hof et al., 1997; Hodgson et al.,
2000; Hodgson et al., 2001; O’Reilly
et al., 2001; Steptoe et al., 2007)
174 OSN
Reduction of oxidative stress in
chronic artery disease
1 (Widlansky et al., 2005) 66 OSN
Reduction of inflammation in
chronic artery disease
1 (Widlansky et al., 2005) 66 OSN
TOTAL 7a 268b 0c 0d
∗OSN: other studies needed; a) number of studies where the effect was not observed; b) the total number of subjects recruited in the studies which reported no
benefit; c) number of studies where the effect was observed; d) the total number of subjects recruited in the studies which reported benefit.
treatment (Table 4). Other biomarkers did not change. A single
study (Bitler et al., 2007) reported a reduction of pain evaluated
by DAS-28 (Disease Activity Score-28) scoring system, and
an improvement of the quality of life determined by HAQ-DI
(Health Assessment Questionnaire Disability Index) in 105 sub-
jects with arthritis. However, the number of recruited subjects
is insufficient for supporting efficacy. As a general comment,
more studies are needed before an anti-inflammatory effect may
be claimed for olive oil.
Epidemiology Studies
The bibliographic search retrieved 24 papers for Vitis vinifera
L., 144 papers for Camellia sinensis L., 23 papers for Matricaria
recutita L., and 48 papers for Olea europea L. By application
of the exclusion criteria, 13 studies related to Camellia sinensis
L. (Table 5) and 5 related to Olea europea L. (Table 6) were
accepted through the in/out process and used for this review.
No study could be accepted for Vitis vinifera and Matricaria
recutita.
The main outcome variables investigated by epidemiological
studies in relation to PFS exposure were biological markers of
inflammation and risk of atrophic gastritis, rheumatoid arthri-
tis, and various other conditions differing from one study to
another. Three cross-sectional studies on Camellia sinensis L.,
(as green or black tea) (De Bacquer et al., 2006; Chun et al.,
2008; Maki et al., 2010), investigated the relation to CRP, with
only one of these (De Bacquer et al., 2006) on 1031 healthy
men from Belgium found a significant correlation of black tea
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Table 4 Clinical studies considering the effect of Olea europea L. (olive oil) on biomarkers and/or hard endpoints
No benefit Benefit
N◦ studies
N◦
participants N◦ studies
N◦
participants
Comments
Efficacy
Biomarkers
MMPs (1,2,3,9,13) 1 (Bitler et al., 2007) 105 OSN∗
ILs (1β,8) 1 (Bitler et al., 2007) 105 OSN
C reactive protein 1 (Bitler et al., 2007) 105 1 (Konstantinidou et al., 2010) 90 OSN
VCAM-1 3 (Fuentes et al., 2008; Pacheco et al.,
2008; Mena et al., 2009)
174 YES
ICAM-1 3 (Pacheco et al., 2008; Corella et al., 2009;
Mena et al., 2009)
875 YES
IL-6 1 (Bitler et al., 2007) 105 2 (Corella et al., 2009; Mena et al., 2009) 833 YES
E-selectin 1 (Mena et al., 2009) 112 OSN
Nitrate/nitrite 1 (Fuentes et al., 2008) 20 OSN
NO 1 (Fuentes et al., 2008) 20 OSN
Isoprostanes 1 (Konstantinidou et al., 2010) 90 OSN
IL-10 gene 1 (Konstantinidou et al., 2010) 90 OSN
MCP-1 1 (Konstantinidou et al., 2010) 90 OSN
IFN-gamma 1 (Konstantinidou et al., 2010) 90 OSN
TOTAL 3a 215b 5c 985d
Hard end-points
Pain 1 (Bitler et al., 2007) 105 OSN
HAQ-DI 1 (Bitler et al., 2007) 105 OSN
TOTAL 0a 0b 1c 105d
∗OSN: other studies needed; a) number of studies where the effect was not observed; b) the total number of subjects recruited in the studies which reported no
benefit; c) number of studies where the effect was observed; d) the total number of subjects recruited in the studies which reported benefit.
consumption with CRP, and also with serum amyloid A and
haptoglobin. Fibrinogen levels were not different between ha-
bitual tea consumers and nonconsumers in this study. The other
two studies, one on 10325 men and women aged 49–76 years
in Japan (Maki et al., 2010), and the other in USA, on 8335
subjects ≥19 years (Chun et al., 2008), found no correlation of
tea consumption with serum CRP. A prospective cohort study in
USA found that intake of 2 or more cups of tea per day tended
to be associated with higher adiponectin concentrations among
diabetic women, but the association remained not significant
after adjusting for lifestyle and medical history covariates (p =
0.07) (Williams et al., 2008).
Considering the modification of inflammation biomarkers,
the general trend allows sustaining that the consumption of
Table 5 Epidemiological studies considering the effect of Camellia sinensis L. on biomarkers and/or hard endpoints
No benefit Benefit
N◦ studies
N◦
participants N◦ studies
N◦
participants
Comments
Efficacy
Biomarkers
CRP 3 (Song et al., 2005; Chun et al., 2008;
Maki et al., 2010)
19004 1 (De Bacquer et al., 2006) 1031 NO
IL-6 1 (Song et al., 2005) 344 OSN
Serum amyloid A and haptoglobin 1 (De Bacquer et al., 2006) 1031 OSN
Adiponectin 1 (Williams et al., 2008) 2040 OSN
Fibrinogen 1 (De Bacquer et al., 2006) 1031 OSN
TOTAL 5a 22075b 1c 1031d
Hard end-points
Atrophic gastritis 1 (Kuwahara et al., 2000) 566 2 (Shibata et al., 2000; Setiawan et al.,
2001)
1368 OSN
COPD 1 (Tabak et al., 2001) 13651 OSN
Asthma 2 (Shaheen et al., 2001; Garcia et al.,
2005)
1471 OSN
Periodontal disease 1 (Kushiyama et al., 2009) 940 OSN
TOTAL 4a 15688b 3c 2308d
∗OSN: other studies needed; a) number of studies where the effect was not observed; b) the total number of subjects recruited in the studies which reported no
benefit; c) number of studies where the effect was observed; d) the total number of subjects recruited in the studies which reported benefit.
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Table 6 Epidemiological studies considering the effect of Olea europea L. (olive oil) on biomarkers and/or hard endpoints
No benefit Benefit
N◦ studies
N◦
participants N◦ studies
N◦
participants
Comments
Efficacy
Biomarkers
VCAM-1 2 (Serrano-Martinez et al., 2005;
Salas-Salvado et al., 2008)
796 OSN∗
ICAM-1 1 (Salas-Salvado et al., 2008) 772 OSN
IL-6 1 (Salas-Salvado et al., 2008) 772 OSN
CRP 1 (Salas-Salvado et al., 2008) 772 1(Esmaillzadeh and Azadbakht, 2008) 486 OSN
TNFα 2 (Serrano-Martinez et al., 2005;
Esmaillzadeh and Azadbakht, 2008)
510 OSN
sICAM-1 1 (Esmaillzadeh and Azadbakht, 2008) 486 OSN
TOTAL 1a 772b 3c 1282d
Hard end-points
Rheumatoid arthritis 0 0 2 (Linos et al., 1991; Linos et al., 1999) 638 OSN
TOTAL 0a 0b 2c 638d
∗OSN: other studies needed; a) number of studies where the effect was not observed; b) the total number of subjects recruited in the studies which reported no
benefit; c) number of studies where the effect was observed; d) the total number of subjects recruited in the studies which reported benefit.
Camellia sinensis L. does not affect these parameters signifi-
cantly (22,075 subjects recruited in studies reporting no benefits
vs. 1031 with benefits).
Similar discomforting results are observed in studies where
the effect of green tea consumption was investigated in pa-
tients with various inflammatory diseases: 15,688 subjects were
recruited in studies reporting no benefits versus 2308 report-
ing benefits. In a cross-sectional study in Japan (Shibata et al.,
2000), and a case-control study in China (Setiawan et al., 2001),
the protective effect against atrophic gastritis could only be ob-
served when daily consumption was very high and/or in the case
of long time consumption. In the study on 166 gastritis cases
and 433 healthy controls in China, green tea drinkers had a 51%
lower risk of chronic gastritis than nondrinkers after adjusting
for potential confounders and a dose-response relationship with
years of green tea drinking. In the study conducted in Japan on
636 subjects aged 30 years or older (mean age: 50.2), high green
tea consumption (>10 cups/day) was negatively associated with
the risk of atrophic gastritis, even after adjustment for H. pylori
infection and lifestyle factors associated with green tea con-
sumption (OR = 0.63; 95% CI, 0.43–0.93) (Shibata et al., 2000).
In a third cross-sectional study conducted in Japan, performed
on 566 men, 50–55 years, the association between green-tea
consumption and a small decrease in the risk of chronic atrophic
gastritis was statistically nonsignificant (Kuwahara et al., 2000).
Epidemiological studies found for Olea europea L. investi-
gated the effects of olive oil or nonpartially hydrogenated veg-
etable oils (HVO), including olive oil (non-HVOs) in the diet
(Esmaillzadeh and Azadbakht, 2008).
Two case-control studies performed in Greece suggest a pro-
tective effect of olive oil consumption for rheumatoid arthritis
(Linos et al., 1991; Linos et al., 1999). Two studies performed in
Spain (Serrano-Martinez et al., 2005; Salas-Salvado et al., 2008)
found a beneficial correlation between olive oil consumption and
vascular cell adhesion molecule 1 VCAM-1 in patients with high
cardio-vascular risk or unstable angina. A cross-sectional study
performed in Iranian females a higher consumption of non-
HVOs was associated with lower circulating concentrations of
serum amyloid A, TNF, CRP, and sICAM-1; however, olive oil
consumption was not investigated separately from other non-
HVOs in this study.
In view of the data available from epidemiology and interven-
tional/human studies, the consumption of olive oil has sufficient
credit to suggest the necessity of other studies for a claim of
efficacy. Conversely for green tea, both intervention/human tri-
als and epidemiology do not support the reduction on factors
involved in the development of inflammatory states.
CONCLUSIVE REMARKS AND FUTURE WORK
The aim of this systematic review was to evaluate efficacy
of PFS against inflammation and to direct researchers, health
authorities, decision-makers/opinion leaders, about future re-
search for the purpose of making claims on product labels or in
promotional material. This review is the first part of a reviewing
process of studies (clinical, interventional, and epidemiological)
performed with PFS derived from plants known for their use in
inflammatory conditions.
The conditions against which the PFS discussed in the present
review were employed, are osteoarthritis, chronic pancreatitis,
ulcerative colitis, type-2 diabetes, and inflammation associated
to cardiovascular and kidney diseases. Among the reviewed
studies, 43% were performed on healthy subjects.
The outcome of the evaluation process indicates for the need
of well-designed randomized controlled trials for Matricaria
recutita L., Vitis vinifera L., and olive oil. For these PFS, though
the studies are insufficient, all outcomes support for a positive
effect. Conversely, while the potential benefits of green tea have
been reported in a wide range of health areas, and in particular
metabolic syndrome (Williamson et al., 2011), the consumption
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ità
 de
gli
 St
ud
i d
i M
ila
no
] a
t 0
9:0
3 3
0 J
an
ua
ry
 20
13
 
PLANT FOOD SUPPLEMENTS HAVING ANTI-INFLAMMATORY PROPERTIES 411
of green tea does not seem to affect significantly inflammation
conditions.
Major drawbacks hampering the assessment of the benefi-
cial health effect are insufficient characterization of PFS, and
heterogeneity in dosing and time of exposure between studies.
More uniformity of the target organ would be advisable, since
it is difficult to compare an effect on the brain with that on
the gastrointestinal tract. Where it is possible to identify likely
active components within PFS, these levels should be reported
to allow for future stratified meta-analysis. Interventions should
be carried out over a timescale sufficient to observe a change in
the endpoint measured. Studies must be controlled for the full
length of the intervention, and the placebo effect must be in-
cluded. The use of solely positive controls where a high placebo
effect might be reasonably expected could be considered mis-
leading. The metabolism of suspected active ingredients must
be considered during study design, randomization, and analysis.
The use of an adequate statistical analysis must be considered
as a priority to evaluate the good quality of the work.
In conclusion, in the future, it is advisable to conduct studies
with more homogeneous population and larger number of sub-
jects by avoiding the heterogeneity of the herbal preparations
considered.
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